Prospects for developmental immunotoxicity guidance and an update on ICH S8

Area of Science:

• Toxicology
• Immunology
• Pharmacology

Background:

• Drug-induced immunotoxicity in developing immune systems was historically under-researched.
• Regulatory focus on pediatric drug evaluation necessitates detailed juvenile animal studies.
• Assessing immunotoxicity in juvenile animals is now a key part of pediatric drug development.

Purpose of the Study:

• To summarize discussions on developmental immunotoxicity assessment in drug development.
• To highlight the implications of the International Council for Harmonisation (ICH) S8 guidance.
• To discuss the shift towards a weight-of-evidence approach for immunotoxicity testing.

Main Methods:

• Review of current regulatory trends in pediatric drug safety evaluation.
• Analysis of the ICH S8 guidance on safety studies for pharmacologics.
• Summary of expert workshop discussions on risk assessment for developmental immunotoxicity.

Main Results:

• The ICH S8 guidance is nearing final approval, likely recommending juvenile animal immunotoxicity studies.
• The guidance supports a flexible, weight-of-evidence approach, not routine screening.
• Immunotoxicity testing should be triggered by specific concerns rather than being a standard procedure.

Conclusions:

• Developmental immunotoxicity is a critical consideration in modern drug safety assessment.
• The ICH S8 guidance provides a framework for evaluating these risks.
• A targeted, evidence-based approach to immunotoxicity testing is advocated.